Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Cash Flow Quality Index
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Cash Flow Quality Index of 0.05x as of September 2025. Operating cash flow of CN¥833.94K is below net income of CN¥18.51 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Chongqing Pharscin Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Chongqing Pharscin Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Chongqing Pharscin Pharmaceutical Co Ltd.
Annual Cash Flow Quality Index for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Chongqing Pharscin Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.11x | CN¥161.77 Million | CN¥76.73 Million | ▼ -68.6% |
| 2023 | 6.71x | CN¥219.34 Million | CN¥32.70 Million | ▲ +4959.9% |
| 2022 | 0.13x | CN¥13.04 Million | CN¥98.40 Million | ▼ -85.3% |
| 2021 | 0.90x | CN¥82.85 Million | CN¥91.78 Million | ▼ -5.3% |
| 2020 | 0.95x | CN¥113.64 Million | CN¥119.19 Million | ▲ +145.5% |
| 2019 | 0.39x | CN¥65.92 Million | CN¥169.75 Million | ▲ +67.8% |
| 2018 | 0.23x | CN¥31.80 Million | CN¥137.37 Million | ▼ -68.1% |
| 2017 | 0.73x | CN¥81.34 Million | CN¥111.99 Million | ▲ +20.4% |
| 2016 | 0.60x | CN¥57.73 Million | CN¥95.71 Million | ▼ -33.7% |
| 2015 | 0.91x | CN¥66.10 Million | CN¥72.69 Million | ▲ +166.7% |
| 2014 | 0.34x | CN¥20.22 Million | CN¥59.30 Million | ▼ -79.1% |
| 2013 | 1.64x | CN¥47.34 Million | CN¥28.95 Million | — |